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Scavenging of nitric oxide (NO) often interferes with studies on NO signaling in cell-free preparations.
We observed that formation of cGMP by NO-stimulated puriﬁed soluble guanylate cyclase (sGC) was
virtually abolished in the presence of cytosolic preparations of porcine coronary arteries, with the
scavenging activity localized in the tunica media (smooth muscle layer). Electrochemical measurement of
NO release from a donor compound and light absorbance spectroscopy showed that cytosolic prepara-
tions contained a reduced heme protein that scavenged NO. This protein, which reacted with anti-human
hemoglobin antibodies, was efﬁciently removed from the preparations by haptoglobin afﬁnity chro-
matography. The cleared cytosols showed only minor scavenging of NO according to electrochemical
measurements and did not decrease cGMP formation by NO-stimulated sGC. In contrast, the column
ﬂow-through caused a nearly 2-fold increase of maximal sGC activity (from 33.1 ± 1.6 to
54.9 ± 2.2 mmolmin1mg1). The proteins retained on the afﬁnity column were identiﬁed as he-
moglobin a and b subunits. The results indicate that hemoglobin, presumably derived from vasa vasorum
erythrocytes, is present and scavenges NO in preparations of porcine coronary artery smooth muscle.
Selective removal of hemoglobin-mediated scavenging unmasked stimulation of maximal NO-stimulated
sGC activity by a soluble factor expressed in vascular tissue.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
As a signaling molecule nitric oxide (NO) is involved in a variety
of physiological and pathological processes ([1e3]). In the vascu-
lature NO plays a major role in maintaining homeostasis by causing
smooth muscle relaxation as well as inhibition of platelete phosphate; CK, creatine ki-
DTPA, diethylene triamine
glycol tetraacetic acid; Hb,
methylxanthine; GTN, nitro-
ries; PBS, phosphate buffered
el electrophoresis; SOD, su-
EA, triethanolamine.
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oldtstrasse 46/I, 8010, Graz,
Inc. This is an open access article uaggregation and cell proliferation [4]. Vascular NO is bio-
synthesized from the amino acid L-arginine by endothelial NO
synthase [5] and acts through activation of soluble guanylate
cyclase (sGC) in the adjacent smooth muscle layer, resulting in
accumulation of 30,50-cyclic GMP (cGMP) and vascular relaxation
([6e8]). Many cardiovascular diseases, in particular coronary artery
disease, are associated with endothelial dysfunction evident as
impaired NO signaling in blood vessels [9]. The mechanisms un-
derlying the development of endothelial dysfunction are manifold,
but scavenging of NO by superoxide anion generated in conditions
of oxidative stress is considered as a major culprit [10]. Thus, be-
sides substituting endogenous NO with donor compounds such as
nitroglycerin, which release NO in the vasculature, antioxidants
and superoxide scavengers are promising tools for the treatment of
endothelial dysfunction [11].
In the course of our ongoingwork on themolecular mechanisms
of vascular GTN bioactivation, we discovered a pathway of GTN-
induced relaxation of bovine and porcine blood vessels that doesnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lyzing GTN biotransformation in human and rodent vessels [12].
Although GTN caused potent cGMP-mediated endothelium-inde-
pendent relaxation of porcine coronary arteries (PCA), the rates of
GTN denitration were about 10-fold lower than ALDH2-catalyzed
denitration in vessels from rats, mice and guinea pigs, suggesting
the presence of a highly efﬁcient mechanism of GTN biotransfor-
mation that yields stoichiometric amounts of 1,2-glycerol dinitrate
and NO. Since relaxation was not signiﬁcantly affected by any drug
reported previously to interfere with GTN bioactivity, we wished to
mimic GTN-induced cGMP formation in cell-free preparations in
order to enable isolation and biochemical characterization of the
active principle. However, both total homogenates as well as
cytosolic PCA preparations exhibited extensive NO scavenging that
was not prevented by up to 1000 U/ml of superoxide dismutase
(SOD), indicating a superoxide-independent pathway. It was the
aim of the present study to characterize the underlying mechanism
and, if possible, to remove the scavenging principle from the
cytosolic coronary artery preparations.
2. Materials and methods
2.1. Materials
Bovine lung sGC was puriﬁed as described [13]. Polyclonal an-
tibodies against Hb subunit a were obtained from Santa Cruz
(Heidelberg, Germany). 2,2-Diethyl-1-nitroso-oxyhydrazine (DEA/
NO) was from Enzo Life Sciences (Lausen, Switzerland) and ob-
tained via Eubio (Vienna, Austria). [a-32P]GTP (800 Ci/mmol; NEN
Radiochemicals) was obtained from PerkinElmer Life and Analytical
Sciences (Vienna, Austria). All other chemicals, including horse-
radish peroxidase-conjugated anti-rabbit IgG, Hb (bovine, lyophi-
lized), and Sepharose® 4B were obtained from SigmaeAldrich
(Vienna, Austria).
2.2. Preparation of cytosols
Porcine hearts and aortas were obtained from a local slaugh-
terhouse and immediately transported to the laboratory. Coronary
arteries were carefully explanted and surrounding fat and con-
nective tissue were dissected. After multiple washes in ice-cold
PBS, tissue was cut in small pieces with scissors and incubated in
collagenase type II solution (1.5 mg/ml in 10 mM TriseHCl buffer,
containing 125 mM KCl, 3 mM CaCl2, 100 U/ml penicillin, 0.1 mg/ml
streptomycin, and 1.25 mg/ml amphotericin B, pH 7.4) for 3e4 h at
ambient temperature. After removing collagenase and washing
vigorously with PBS, tissue was homogenized in 10 mM TriseHCl
buffer (pH 7.4), containing 125 mM KCl, 5 mM EGTA, and 2 mM
MgCl2 using a glass-teﬂon Potter-Elvehjem homogenizer. Homog-
enates were centrifuged at 100,000 g for 1.5 h. Supernatants were
collected, concentrated by ultraﬁltration (Merck ultra ﬁltration
chamber, 10 kDa molecular weight cut off), and regarded as cyto-
sols. They were stored at 80 C until use.
To obtain cytosols from different aortic layers, surrounding tis-
sue was dissected from porcine aortas and the vessels were cut
open longitudinally. After rinsing with ice-cold PBS tunica intima
(endothelium and basal lamina), tunica media (smooth muscle) and
tunica adventitia (outermost connective tissue) were separated
using forceps and scalpel. The individual layers were processed as
described for coronary arteries.
Cytosolic preparations were reduced or oxidized by addition of
sodium dithionite (~1 mg/ml) or potassium ferricyanide (~1 mg/
ml), respectively. Both compounds were subsequently removed
from cytosols using PD-10 desalting columns (GE Healthcare,
Vienna, Austria).Protein concentration was determined with the Pierce BCA™
Protein Assay Kit (Fisher Scientiﬁc Austria GmbH, Vienna, Austria).
2.3. Determination of sGC activity
Puriﬁed bovine lung sGC (50 ng) was incubated at 37 C for
10 min in a ﬁnal volume of 0.1 ml in the presence of the different
vascular preparations (as indicated in the ﬁgure legends). Assay
mixtures contained 50 mM TEA (pH 7.4), 0.5 mM [a-32P]GTP
(~200,000 cpm), 3 mM MgCl2, 1 mM cGMP, 1 mM IBMX, 1 mM
EGTA, 2mMDTT, 0.1 mMDTPA, 5mMCP,152 U/l CK, and 1000 U/ml
SOD. Reactions were started by addition of DEA/NO (ﬁnal concen-
tration as indicated in the text and ﬁgure legends) and terminated
by the addition of 0.45 ml zinc acetate (120 mM) and 0.45 ml so-
dium bicarbonate (120 mM). After centrifugation (20,000  g at
4 C for 10 min) supernatants were applied onto Al2O3 columns
(acidiﬁed with 0.1 M perchloric acid). After washing the columns
with distilled water, 32P-cGMP was eluted with sodium acetate
(50 mM) and quantiﬁed by liquid scintillation counting. Blank
values were measured in the absence of sGC.
2.4. Determination of nitric oxide
NO concentration was monitored electrochemically with a
Clark-type electrode (World Precision Instruments, Berlin, Ger-
many) as described previously [14]. The electrode was calibrated
daily with acidiﬁed nitrite after equilibration in a solution of KJ
(100 mM) in H2SO4 (100 mM).
For the determination of cytosolic NO consumption, the elec-
trode was equilibrated in 50 mM TEA buffer (pH 7.4) containing the
indicated amounts of cytosolic protein. Unless stated otherwise, the
ﬁnal volumewas 500 ml. Measurements were performed in an open
vessel under constant stirring at 37 C after injection of DEA/NO
(ﬁnal concentration as indicated in the ﬁgure legends).
2.5. Light absorbance spectroscopy
Light absorbance spectra were recorded with a HewlettePack-
ward 8452A Diode Array spectrophotometer in 1 cm quartz cu-
vettes that allow measurements in volumes of 300 ml. Average
absorbances between 700 and 800 nm were subtracted from each
spectrum. Absorbance at speciﬁc wavelengths was corrected for
background by three-point drop line. The heme content of the
preparations was calculated with an extinction coefﬁcient of
15.3 mM1 cm1 at 576 nm [15].
2.6. Preparation of Haptoglobin-Sepharose® column
Haptoglobin (Hp) was isolated from porcine plasma by afﬁnity
chromatography as described [16]. For this purpose, 50 mg of
bovine Hb was coupled to cyanogen bromide-activated Sepharose®
4B (1 g of powder) according to themanufacturers instructions. The
Hb-Sepharose®was then packed into a Poly-Prep® chromatography
column (Bio-Rad, Vienna, Austria).
In order to isolate Hp, fresh porcine blood (immediately mixed
with EDTA, ﬁnal concentration 0.1%) was obtained from a local
slaughterhouse. After centrifugation (3000  g at 4 C for 20 min)
non-hemolytic plasma was mixed with solid ammonium sulfate to
yield 30% saturation. After equilibration for 20 min at 4 C under
constant stirring, the precipitate was separated by centrifugation at
10,000  g for 10 min and discarded. The ammonium sulfate
saturation in the supernatant was raised to 60% by further addition
of solid ammonium sulfate. After equilibration for 30 min at 4 C
under constant stirring, the precipitate was collected by centrifu-
gation at 20,000  g for 20 min, redissolved in binding buffer
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buffer over night with several changes of the solution. The dialysate
was passed through the Hb-Sepharose® column using a peristaltic
pump with a ﬂow rate of 1 ml/min. The columnwas washed with 5
bed volumes (~20 ml) of binding buffer, followed by 10 bed vol-
umes of 1.6 M guanidine in binding buffer (1 ml/min). Hp was
eluted with 3.5 M guanidine in binding buffer (pH 5.0), collected in
2-ml fractions and analyzed by SDS-PAGE. The binding buffer was
removed from pooled Hp containing fractions by ultraﬁltration
(Amicon® ultra centrifugal ﬁlters, 50 kDa molecular weight cutoff,
Merck-Millipore, Vienna, Austria) and replaced by 0.1 M NaHCO3
(pH 8.4), containing 0.5 M NaCl. Finally, Hp was coupled to cyan-
ogen bromide-activated Sepharose® 4B according to the manufac-
turer's instructions and placed into a Poly-Prep® column.
2.7. Electrophoresis and western blotting
PCA cytosol (1 ml) was loaded onto the Hp-afﬁnity column and
allowed to pass through by gravity. The ﬂow-through was collected
and used in separate experiments. The column was washed with
10 ml of homogenization buffer (10 mM TriseHCl, containing
125 mM KCl, 5 mM EGTA, and 2 mM MgCl2, pH 7.4) and bound
protein was subsequently eluted with 3.5 M guanidine (in 0.01 M
TriseHCl, containing 0.5 M NaCl, pH 5.0). Samples were concen-
trated by ultraﬁltration using Amicon® Ultra centrifugal ﬁlters
(10 kDa molecular weigh cutoff, Merck-Millipore, Vienna, Austria),
and the buffer replaced by an equal volume of distilled water. This
desalting step was repeated once, and samples were eventually
concentrated by ultraﬁltration. Lysates from human and porcine
erythrocytes were used as standards and prepared as follows:
100 ml of blood was mixed with 900 ml of PBS and centrifuged at
3000  g for 5 min at 4 C. The supernatant was discarded and the
pellet (i.e. mainly erythrocytes) was resuspended in 1 ml of PBS.
The washed erythrocytes were sedimented by centrifugation at
3000  g for 5 min at 4 C. The supernatant was discarded and the
pellet resuspended in 500 ml of 10 mM TriseHCl (pH 7.4) andmixed
vigorously to lyse erythrocytes. After incubation for 10 min at 4 C
cell debris were sedimented by centrifugation at 20,000  g for
10 min at 4 C, and the clear red supernatant was collected. Eluates
and erythrocyte lysates were stored at 20 C. For SDS-PAGE, they
were mixed with an equal volume of sample buffer (50 mM
TriseHCl, containing 1.6% sodium dodecyl sulfate (w/v), 7% glycerol
(v/v), 8 M urea, 5% 2-mercaptoethanol (v/v), and 0.016% bromo-
phenol blue (w/v), pH 6.8) and denatured for 5 min at 95 C. De-
natured eluates and lysates (10 and 0.5 mg of protein, respectively)
were separated by SDS-PAGE on 15% gels and transferred onto
nitrocellulose membranes (0.45 mm). After blocking with 5% nonfat
dry milk ((w/v) in Tris-buffered saline, containing 0.05% Tween-20
(v/v)) for 1 h, membranes were incubated overnight at 4 C with
polyclonal primary antibodies against human hemoglobin subunit
a (1:1000). After incubation of membranes with horseradish
peroxidase-conjugated anti-rabbit IgG (1:5000), immunoreactive
bands were visualized by chemiluminescence using ECL Prime
Western Blot Detection Reagent (GE Healthcare, purchased via
VWR, Vienna, Austria).
2.8. LC-MS/MS analysis of proteins retained on the Hp afﬁnity
column
The concentrated guanidine eluate (see above) was separated by
SDS-PAGE and stained with Coomassie-brilliant blue. Bands were
excised from the gel, tryptically digested and analyzed by nanoLC-
ESI-MS/MS as described elsewhere [17]. MS/MS spectra were
identiﬁed by search of the Swiss-Prot non-redundant public data-
base using SpectrumMill software (Agilent). The following searchparameters were used: tryptic digestionwith onemissing cleavage;
carbamidomethylation as ﬁxed modiﬁcation; oxidized methionine,
N-terminal pyro-glutamic acid, acrylamide at cysteine as variable
modiﬁcations; sequence tag length >3; minimumdetected peaks of
4; minimum matched peak intensity of 50%; precursor ion mass
tolerance of ±2.5 Da, and product mass tolerance of ±0.7 Da.
Acceptance parameters were three or more identiﬁed distinct
peptides with minimum sequence coverage of 20% and probability
score of >95%.
3. Results
3.1. NO scavenging of PCA cytosols
As shown in Fig. 1A, puriﬁed sGC exhibited a speciﬁc activity of
37.9 ± 3.2 mmol cGMPmin1mg1 in the presence of 0.1 mM
DEA/NO. Formation of cGMP was almost completely abolished by
PCA cytosols (0.1 mg of protein), resulting in an apparent sGC ac-
tivity of 2.0 ± 0.6 mmol cGMPmin1mg1, which was virtually
identical to the basal activity of the enzyme in the absence of NO
stimulation (not shown). Similar results were obtained with cyto-
solic preparations of the smooth muscle layer (tunica media) of
porcine aortas (6.3 ± 3.5 mmolmin1mg1), while the inner-
most part of the aortas (tunica intima, mainly consisting of the
endothelium) had no effect.
The data clearly indicate that interference with NO-stimulated
sGC activity is located in the smooth muscle layer and not a spe-
ciﬁc feature of coronary arteries. The effect was observed in the
presence of the non-selective phosphodiesterase inhibitor IBMX
and a GTP regenerating system and, moreover, not prevented by a
phosphatase inhibitor cocktail (PhosSTOP®, Roche) (not shown),
excluding the involvement of enzymatic cGMP hydrolysis or
limited substrate availability through GTPase activity. Therefore, we
considered that the cytosolic preparations efﬁciently scavenged NO
released from DEA/NO.
Fig. 1B shows representative traces of NO release from 1 mM
DEA/NO measured with a Clark-type electrode. Addition of PCA
cytosols decreased the NO signal and delayed its appearance in a
protein-dependent manner. In the presence of 0.1 mg of cytosolic
protein the NO signal was reduced to 50% as compared to buffer
controls, and 0.8 mg of protein completely abolished the NO signal.
These results strongly suggest that cytosolic preparations of blood
vessels interfere with sGC-catalyzed cGMP formation through
consumption of DEA/NO-derived NO.
Although scavenging was observed in the presence of a high
concentration of SOD (1000 U/ml), we considered that the reaction
of NO with NADPH oxidase-derived superoxide [18], resulting in
formation of peroxynitrite [19], could be involved. However, several
NADPH oxidase inhibitors, including the well established inhibitor
diphenyleneiodonium [20], had no effect (data not shown).
3.2. UV/Vis spectroscopy of PCA cytosols
Based on these results we speculated that NO could be scav-
enged by a reduced heme protein present in PCA cytosols. Cyto-
globin was identiﬁed as a soluble scavenging heme protein in
vascular smoothmuscle [21], and hemoglobin awas shown to limit
NO diffusion through myoendothelial junctions if reduced by cy-
tochrome b5 reductase 3 [22]. To test whether high afﬁnity binding
of NO to reduced (ferrous) heme iron contributes to NO scavenging,
we recorded UV/Vis spectra of PCA cytosols under control condi-
tions and after reduction and oxidation by dithionite and ferricy-
anide, respectively. Fig. 1C shows that the untreated preparations
exhibited a Soret band at 413 nm and a/b bands at 540 and 576 nm.
This spectrum is virtually identical to that of O2-bound hemoglobin
Fig. 1. A: Formation of cGMP by puriﬁed sGC (50 ng) in the presence of 0.1 mM DEA/NO with and without cytosolic preparations of tunica intima and tunica media from porcine
aortas or PCA (0.1 mg of protein each). Data are mean values ± S.E.M. of three independent experiments. B: NO release from 1 mM DEA/NO measured with a Clark-type electrode in
the presence of increasing amounts of PCA cytosol (0.1e0.8 mg). The traces are representative for three individual experiments. C: Representative UV/Vis spectra of PCA cytosols
reduced or oxidized with sodium dithionite (~1 mg/ml) and ferricyanide (~1 mg/ml), respectively. D: Correlation of NO scavenging with heme content of the preparations. The
amount of NO (released from 0.5 mM DEA/NO) that was consumed by 200 mg of total cytosolic protein (200 ml ﬁnal volume) was plotted against the corresponding heme content.
Each data point represents an individual preparation.
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while ferricyanide caused a blue-shift of the Soret band to 405 nm
and loss of the a/b bands, indicating that PCA cytosols contain a
reduced heme protein that is oxidized by ferricyanide.
According to the absorbance at 576 nm, the heme content of the
various preparations varied between 140 and 470 pmol/mg of total
protein. This allowed us to correlate the scavenging efﬁcacy of the
preparations with their heme content. As shown in Fig. 1D, there
was a positive correlation (R ¼ 0.942) between NO consumption
(released from 0.5 mMDEA/NO) and heme content. The slope of the
linear regression shown in Fig. 1D was 0.73, indicating that about0.7 mol of NO were consumed per mol of heme. These results
strongly suggest that NO is scavenged by a reduced heme protein
present in the cytosolic preparations of porcine blood vessels.
3.3. Effects of heme iron oxidation on NO scavenging by PCA cytosol
As shown in Fig. 2A, the effect of cytosolic PCA protein (0.1 mg)
on sGC activation by DEA/NO (0.1 mM) was prevented by pretreat-
ment of the preparations with the heme oxidant ferricyanide
(1.6 ± 0.5 and 32.5 ± 5.2 mmolmin1mg1 in the presence of
untreated and oxidized PCA cytosols, respectively). Likewise
Fig. 2. A: Formation of cGMP by puriﬁed sGC (50 ng) in the presence of 0.1 mM DEA/NO in the absence or presence of PCA cytosols (0.1 mg of protein) that were either untreated or
oxidized with ferricyanide (1 mg/ml), followed by desalting to remove the oxidant. Data are mean values ± S.E.M. of three independent experiments. B: NO release from 1 mM DEA/
NO measured with a Clark-type electrode in the absence or presence of PCA cytosols (0.1 mg of protein) that were either untreated or oxidized with 1 mg/ml ferricyanide. The traces
are representative for three individual experiments.
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completely prevented by ferricyanide treatment of the cytosolic
preparations (Fig. 2B).3.4. Selective removal of the NO scavenging heme protein from PCA
cytosols
Since the observed NO scavenging precludes studies on NO-
triggered effects in cell-free preparations of blood vessels, we
developed a method for selective removal of heme proteins from
PCA cytosols. In a ﬁrst attempt, we tried to achieve this by immu-
noprecipitation using antibodies against human Hb subunit a.
However, NO scavenging was not affected by precipitation, pre-
sumably due to relatively low cross-reactivity of the antibody with
porcine Hb. Indeed, dot blots with erythrocyte lysates revealed that
reactivity of the anti-Hb antibody with porcine Hb was about 20-
fold lower than its reactivity with the human protein (data not
shown).
To avoid problems associated with species-speciﬁc binding, af-
ﬁnity chromatography with haptoglobin (Hp), which selectively
binds Hb, was applied ([16,25]). For this purpose we isolated Hp
from porcine plasma and prepared an afﬁnity column by coupling
the protein to cyanogen bromide-activated Sepharose® 4B. As
shown in Fig. 3A, the electrochemical signal obtained with 1 mM
DEA/NO was about 75% of buffer controls in the presence of cyto-
solic preparations (0.4 mg of protein) that had been passed through
the Hp afﬁnity column, while the NO signal was almost completely
abolished by the cytosol prior to chromatography.
The effect of Hp afﬁnity chromatography of PCA cytosols on
DEA/NO-stimulated sGC activity is shown in Fig. 3B. Formation of
cGMP was abolished in the presence of 0.1 mg of protein prior to
chromatography (pre-column), while no considerable reduction
was observedwith up to 0.2mg of PCA cytosol that had been passed
through the afﬁnity column. Surprisingly, sGC activity was
increased almost 2-fold by the post-column fractions (from
33.1 ± 1.6 to 54.9 ± 2.2 mmolmin1mg1). Since endogenous
sGC activity was hardly detectable in PCA cytosols (data not
shown), this observation suggests that the preparations contain a
factor that activates maximal sGC activity. In untreated cytosolicpreparations, this effect is masked by high afﬁnity binding of NO to
a hemoglobin-like protein.
The NO scavenging heme protein was tentatively identiﬁed by
immunoblotting using a speciﬁc antibody against Hb subunit a.
Fig. 3C shows that the antibody reacted with the eluate from the Hp
afﬁnity column (10 mg of protein). The visualized band at 16 kDa
agrees well with the molecular mass of monomeric Hb [26]. Note
the low reactivity of the anti-Hb antibody with porcine as
compared to human erythrocyte lysates. An antibody raised against
cytoglobin detected small amounts of the protein in PCA cytosols
but not in the eluates, suggesting that cytoglobin was not retained
on the Hp column (data not shown).
The proteins retained on the Hp afﬁnity column were eluted
with guanidine, concentrated and identiﬁed by LC-MS/MS as Hb
subunit a (5 peptides identiﬁed, amino acid coverage: 44%, Spec-
trumMill Score: 91) and Hb subunit b (7 peptides identiﬁed, amino
acid coverage: 52%, SpectrumMill Score: 137).4. Discussion
Numerous pathways have been described that consume or
scavenge NO, thereby interfering with downstream NO signaling.
Molecular oxygen is certainly the reactant that is most widely
abundant in cells and tissues. Although NO autoxidation yielding
inorganic nitrite is second order with respect to NO in aqueous so-
lution [27] and, therefore, slowat nanomolar NO concentrations, we
recently found that NO/O2-triggered thiol nitrosation can occur at
physiologically lowNOconcentrations in aﬁrst order reaction that is
stimulated byMg2þ ions ([28,29]). Thus, tissue pO2may regulateNO
availability through nitrosation of cellular thiols. Superoxide anion
fromNADPH oxidases and other sources is another well established
NO scavenger. To avoid the fast, almost diffusion-controlled reaction
ofNOwith superoxide, yieldingperoxynitrite ([30,31]),we routinely
perform sGC assays with cell-free preparations and NO measure-
ments in the presence of high concentrations of SOD (1000 U/ml).
As a free radical, NO reacts rapidly with unpaired electrons in
metal centers of proteins [32]. The most prominent biologically
relevant example is the central heme iron of hemoglobin, which
binds NOwith high afﬁnity, a reaction that is considered to limit the
Fig. 3. A: NO release from 1 mM DEA/NO measured with a Clark-type electrode in the absence or presence of PCA cytosols (0.4 mg of protein) before and after Hp afﬁnity
chromatography (pre- and post-column, respectively). The traces are representative for three individual experiments. B: Formation of cGMP by puriﬁed sGC (50 ng) in the presence
of 0.1 mM DEA/NO and increasing amounts of PCA cytosols before and after Hp afﬁnity chromatography (pre- and post-column, respectively). Data are mean values ± S.E.M. of three
independent experiments. C: Representative immunoblot (n ¼ 3) of the protein (10 mg) that had been eluted from the Hp afﬁnity column with 3.5 M guanidine in 0.01 M TriseHCl,
containing 0.5 M NaCl (pH 5.0) as well as porcine and human erythrocyte lysates (0.5 mg of protein, each). E, eluate from Hp-afﬁnity resin; P, porcine erythrocyte lysate; H, human
erythrocyte lysate.
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[33]. Reduced hemoglobins not only bind NO but exhibit dioxyge-
nase activity, resulting in formation of met-Hb and nitrate, with
efﬁcient turnover requiring associated reductases [34]. The reaction
catalyzed by microbial ﬂavohemoglobins is considered as a phylo-
genetically early mechanism of NO detoxiﬁcation [35]. However,
identiﬁcation of a wide variety of NO dioxygenation pathways in
mammalian tissues indicates that the defense against NO poisoning
is essential for all types of organisms. Moreover, besides NO
detoxiﬁcation, the hemoglobin/NO reaction can be beneﬁcial by
regulating NO-mediated biological processes [36].
In vascular tissue, two hemoglobins were identiﬁed that appear
to be essentially involved in the physiological regulation of NO
signaling, cytoglobin and Hb a subunit. Cytoglobin, an ubiquitously
expressed 21 kDa protein with multiple biological functions [37], is
another heme protein with NO dioxygenase function that was
shown to limit NO availability in vascular smooth muscle [21].
According to Western blot analysis cytoglobin was present in PCA
cytosols but not detected in the Hp afﬁnity column eluates, indi-
cating that it had not been retained on the resin. Thus, cytoglobin
could contribute to the residual NO scavenging observed after Hp
afﬁnity chromatography (cf. Fig. 3A).
The reduced Hb a subunit, expressed in myoendothelial junc-
tions, was shown to bind NO, thereby limiting NO transfer from theendothelium to the underlying vascular smooth muscle cells [22].
NO consumption by Hb a requires continuous recycling of the
reduced (ferrous) protein by cytochrome b5 reductase, suggesting
that a redox switch regulates vascular relaxation by endothelium-
derived NO [38]. Myoendothelial junctions containing Hb a are
expected to be present in the endothelium, but dissection of PCA
indicated that NO scavenging occurred exclusively in the smooth
muscle layer (tunica media; cf. Fig. 1A). Since the scavenging protein
was unequivocally identiﬁed as Hb by amino acid sequencing, it is
conceivable that myoendothelial junctions were removed together
with the smooth muscle layer. However, our preparations con-
tained both a and b subunits, while myoendothelial junctions were
reported to exclusively express Hb a. Contamination of the prepa-
rations with blood-derived Hb appears unlikely, because the ves-
sels were extensively cleaned prior to homogenization. Moreover,
no scavenging occurred in the endothelium, which is expected to
bemore prone to blood-derived contamination than the underlying
smooth muscle layer.
Expression of both subunits of Hb was shown for several cell
types beyond erythrocytes, including mesanglial cells, dopami-
nergic neurons, and alveolar epithelial cells (see Ref. [39] and ref-
erences therein). However, we did not detect Hb in smooth muscle
cells cultured from PCA (data not shown), arguing against unex-
pected Hb biosynthesis in vascular smooth muscle. Specialized
A. Kollau et al. / Nitric Oxide 54 (2016) 8e1414microvessels that migrate from the adventitia into the media,
termed vasa vasorum, are known to supply large blood vessels with
oxygen and nutrients. Neovascularization with vasa vasorum is
considered as an early process that occurs in hypercholesteremia
and promotes coronary atherosclerosis ([40,41]), but the micro-
vessels also play a major role in normal vessel wall biology [42].
Therefore, erythrocytes of vasa vasorum present in themedia of PCA
are the most likely source for Hb a and b identiﬁed as NO scav-
enging proteins in our preparations.
Interestingly, PCA cytosols signiﬁcantly increased the activity of
maximally NO-stimulated puriﬁed sGC after removal of the scav-
enging heme protein. To our knowledge the resulting speciﬁc ac-
tivity of almost 60 mmol cGMPmin1mg1 is the highest
activity ever reported for this enzyme.We are not aware of a similar
effect caused by any agent described in the literature. Work on the
characterization of the active principle is underway in our labora-
tory. This unexpected ﬁnding highlights the importance of identi-
fying and eliminating pathways of NO scavenging that may hamper
biochemical studies on NO signaling in cell-free preparations of
blood vessels and other tissues.
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